R. De LaPaz

A Phase I Study of High-dose BCNU, Etoposide and Escalating-dose Thiotepa (BTE) with Hematopoietic Progenitor Cell Support in Adults with Recurrent and High-risk Brain Tumors

A. Troxel, J. Bruce, K. Papadopoulos, 1999, Journal of Neuro-Oncology.